From the San Francisco Business Times. Shruthi Narayan has blood clots on the brain — in a good way. In fact, because of Narayan and the broader team at Penumbra, the Alameda company she leads has ...

VAL D’ISERE, France--(BUSINESS WIRE)--At last week’s ABC-WIN Seminar, Prof. Dr. Michael Knauth, Director of Neuroradiology, University Hospital of Goettingen, Goettingen, Germany, and President-elect ...

Penumbra, Inc. PEN announced the launch of its Lightning Bolt 7 technology, designed to rapidly remove blood clots with modulated aspiration. The new technology is part of Penumbra's computer-aided ...

Boston Scientific Corp. agreed to buy medical device maker Penumbra Inc. in a deal valued at more than $14 billion to expand in the treatment of blood clots and stroke. Boston Scientific said it will ...

Penumbra, Inc. PEN recently announced the FDA’s clearance and the launch of Lightning Flash 2.0, the next generation computer assisted vacuum thrombectomy (CAVT) system to remove venous thrombus and ...

BOSTON--(BUSINESS WIRE)--Penumbra, Inc. (NYSE:PEN), a global interventional therapies company, today announced U.S. commercial availability of its most advanced thrombectomy device, the ACE™68 ...

Advances in technology are changing the way serious blood clots like pulmonary embolism (PE) are treated. Anticoagulant and thrombolytic therapy have been the standard of care, however, it may take ...

Campaign is led by prominent medical societies to minimize discrepancies in treating blood clot conditions, such as in pulmonary embolism, where there are often delays in care (up to 26% of patients ...

Penumbra, Inc. (NYSE:PEN) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of enrollment in STORM-PE clinical trial. The pivotal, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min At Penumbra Inc. Shruthi Narayan ...